Evidence map›Paper›PMID 39435907›Full record

ArticleEpidemiology (Cambridge, Mass.)2025

Socioeconomic Status, Smoking, and Lung Cancer: Mediation and Bias Analysis in the SYNERGY Study.

Jan Hovanec, Benjamin Kendzia, Ann Olsson, Joachim Schüz, Hans Kromhout, Roel Vermeulen, Susan Peters, Per Gustavsson, Enrica Migliore, Loredana Radoi and 31 more

Abstract read
In one paragraph

Article in Epidemiology (Cambridge, Mass.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

41 authors.

Jan HovanecFrom the Institute for Prevention and Occupational Medicine of the German Social Accident Insurance - Institute of the Ruhr-University Bochum (IPA), Bochum, Germany.ORCID 0000-0003-1811-1465
Benjamin KendziaFrom the Institute for Prevention and Occupational Medicine of the German Social Accident Insurance - Institute of the Ruhr-University Bochum (IPA), Bochum, Germany.
Ann OlssonInternational Agency for Research on Cancer (IARC/WHO), Lyon, France.
Joachim SchüzInternational Agency for Research on Cancer (IARC/WHO), Lyon, France.
Hans KromhoutInstitute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands.
Roel VermeulenInstitute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands.
Susan PetersInstitute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands.
Per GustavssonThe Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Enrica MiglioreCancer Epidemiology Unit, Department of Medical Sciences, University of Turin, Turin, Italy.
Loredana RadoiCenter for Research in Epidemiology and Population Health (CESP), Team Exposome and Heredity, U1018 Inserm, University Paris-Saclay, University Paris Cité, Villejuif, France.
Christine BarulUniversité Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail)-UMR_S 1085, Pointe-à-Pitre, France.
Dario ConsonniEpidemiology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Neil E CaporasoNational Cancer Institute, Bethesda, MD.
Maria Teresa LandiNational Cancer Institute, Bethesda, MD.
John K FieldRoy Castle Lung Cancer Research Programme, Department of Molecular and Clinical Cancer Medicine, The University of Liverpool, Liverpool, United Kingdom.
Stefan KarraschInstitute of Epidemiology, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany.
Heinz-Erich WichmannInstitute of Epidemiology, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany.
Jack SiemiatyckiUniversity of Montreal Hospital Research Center (CRCHUM), Montreal, Canada.
Marie-Elise ParentEpidemiology and Biostatistics Unit, Centre Armand-Frappier Santé Biotechnologie, Institut national de la recherche scientifique, Laval, Quebec, Canada.
Lorenzo RichiardiCancer Epidemiology Unit, Department of Medical Sciences, University of Turin, Turin, Italy.
Lorenzo SimonatoDepartment of Cardiovascular Sciences and Public Health, University of Padova, Padova, Italy.
Karl-Heinz JöckelInstitute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany.
Wolfgang AhrensLeibniz Institute for Prevention Research and Epidemiology-BIPS, Bremen, Germany.
Hermann PohlabelnLeibniz Institute for Prevention Research and Epidemiology-BIPS, Bremen, Germany.
Guillermo Fernández-TardónHealth Research Institute of Asturias, University of Oviedo, ISPA and CIBERESP, Spain.
David ZaridzeDepartment of Epidemiology and Prevention, N.N. Blokhin National Medical Research Centre of Oncology, Moscow, Russia.
John R McLaughlinDalla Lana School of Public Health, University of Toronto, Toronto, Canada.
Paul A DemersOccupational Cancer Research Centre, Ontario Health, Toronto, Canada.
Beata ŚwiątkowskaThe Nofer Institute of Occupational Medicine, Lodz, Poland.
Jolanta LissowskaDepartment of Cancer Epidemiology and Prevention, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Tamás PándicsNational Public Health Center, Budapest, Hungary.
Eleonora FabianovaRegional Authority of Public Health, Banska Bystrica, Slovakia.
Dana MatesNational Institute of Public Health, Bucharest, Romania.
Miriam SchejbalovaInstitute of Hygiene and Epidemiology, 1 Faculty of Medicine, Charles University, Prague, Czech Republic.
Lenka ForetovaMasaryk Memorial Cancer Institute, Brno, Czech Republic.
Vladimír JanoutFaculty of Medicine, Palacky University, Olomouc, Czech Republic.
Paolo BoffettaStony Brook Cancer Center, Stony Brook University, Stony Brook, NY.
Francesco ForastiereEnvironmental Research Group, School of Public Health, Imperial College, London, United Kingdom.
Kurt StraifISGlobal, Barcelona, Spain.
Thomas BrüningFrom the Institute for Prevention and Occupational Medicine of the German Social Accident Insurance - Institute of the Ruhr-University Bochum (IPA), Bochum, Germany.
Thomas BehrensFrom the Institute for Prevention and Occupational Medicine of the German Social Accident Insurance - Institute of the Ruhr-University Bochum (IPA), Bochum, Germany.

Funding

NCI NIH HHS N02 CP001006World Health Organization 001
6 · The paper itself

Abstract

backgroundIncreased lung cancer risks for low socioeconomic status (SES) groups are only partially attributable to smoking habits. Little effort has been made to investigate the persistent risks related to low SES by quantification of potential biases.

methodsBased on 12 case-control studies, including 18 centers of the international SYNERGY project (16,550 cases, 20,147 controls), we estimated controlled direct effects (CDE) of SES on lung cancer via multiple logistic regression, adjusted for age, study center, and smoking habits and stratified by sex. We conducted mediation analysis by inverse odds ratio weighting to estimate natural direct effects and natural indirect effects via smoking habits. We considered misclassification of smoking status, selection bias, and unmeasured mediator-outcome confounding by genetic risk, both separately and by multiple quantitative bias analyses, using bootstrap to create 95% simulation intervals (SI).

resultsMediation analysis of lung cancer risks for SES estimated mean proportions of 43% in men and 33% in women attributable to smoking. Bias analyses decreased the direct effects of SES on lung cancer, with selection bias showing the strongest reduction in lung cancer risk in the multiple bias analysis. Lung cancer risks remained increased for lower SES groups, with higher risks in men (fourth vs. first [highest] SES quartile: CDE, 1.50 [SI, 1.32, 1.69]) than women (CDE: 1.20 [SI: 1.01, 1.45]). Natural direct effects were similar to CDE, particularly in men.

conclusionsBias adjustment lowered direct lung cancer risk estimates of lower SES groups. However, risks for low SES remained elevated, likely attributable to occupational hazards or other environmental exposures.

Indexed as

Lung NeoplasmsSmokingSocial ClassAdultAgedBiasCase-Control StudiesFemaleHumansLogistic ModelsMaleMediation AnalysisMiddle AgedRisk FactorsSelection Bias

Identifiers

PMID39435907
PMCPMC12684412

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.